BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 34373857)

  • 1. Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice.
    Alvarado DM; Son J; Thackray LB; Diamond MS; Ding S; Ciorba MA;
    bioRxiv; 2021 Aug; ():. PubMed ID: 34373857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators.
    Gkogkou E; Barnasas G; Vougas K; Trougakos IP
    Redox Biol; 2020 Sep; 36():101615. PubMed ID: 32863223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
    Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
    J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of SARS-CoV-2 related factors ACE2 and TMPRSS2 expressions in gastrointestinal tissue with pathogenesis of digestive symptoms, diabetes-associated mortality, and disease recurrence in COVID-19 patients.
    Kumar A; Faiq MA; Pareek V; Raza K; Narayan RK; Prasoon P; Kumar P; Kulandhasamy M; Kumari C; Kant K; Singh HN; Qadri R; Pandey SN; Kumar S
    Med Hypotheses; 2020 Nov; 144():110271. PubMed ID: 33254575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.
    Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z
    Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD.
    Burgueño JF; Reich A; Hazime H; Quintero MA; Fernandez I; Fritsch J; Santander AM; Brito N; Damas OM; Deshpande A; Kerman DH; Zhang L; Gao Z; Ban Y; Wang L; Pignac-Kobinger J; Abreu MT
    Inflamm Bowel Dis; 2020 May; 26(6):797-808. PubMed ID: 32333601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr Virus Lytic Replication Induces ACE2 Expression and Enhances SARS-CoV-2 Pseudotyped Virus Entry in Epithelial Cells.
    Verma D; Church TM; Swaminathan S
    J Virol; 2021 Jun; 95(13):e0019221. PubMed ID: 33853968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression.
    Pivniouk V; Pivniouk O; DeVries A; Uhrlaub JL; Michael A; Pivniouk D; VanLinden SR; Conway MY; Hahn S; Malone SP; Ezeh P; Churko JM; Anderson D; Kraft M; Nikolich-Zugich J; Vercelli D
    J Allergy Clin Immunol; 2022 Mar; 149(3):923-933.e6. PubMed ID: 34902435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal Protein Characterisation of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in Inflammatory Bowel Disease (IBD) and Fatal COVID-19 Infection.
    McAllister MJ; Kirkwood K; Chuah SC; Thompson EJ; Cartwright JA; Russell CD; Dorward DA; Lucas CD; Ho GT
    Inflammation; 2022 Apr; 45(2):567-572. PubMed ID: 34697723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.
    Kim SH; Kim J; Jang JY; Noh H; Park J; Jeong H; Jeon D; Uhm C; Oh H; Cho K; Jeon Y; On D; Yoon S; Lim SY; Kim SP; Lee YW; Jang HJ; Park IH; Oh J; Seo JS; Kim JJ; Seok SH; Lee YJ; Hong SM; An SH; Kim SY; Kim YB; Hwang JY; Lee HJ; Kim HB; Choi KS; Park JW; Seo JY; Yun JW; Shin JS; Lee HY; Kim K; Lee D; Lee H; Nam KT; Seong JK
    Front Immunol; 2022; 13():1055811. PubMed ID: 36457995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell RNA sequencing of SARS-CoV-2 cell entry factors in the preconceptional human endometrium.
    Vilella F; Wang W; Moreno I; Roson B; Quake SR; Simon C
    Hum Reprod; 2021 Sep; 36(10):2709-2719. PubMed ID: 34329437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal Receptor of SARS-CoV-2 in Inflamed IBD Tissue Seems Downregulated by HNF4A in Ileum and Upregulated by Interferon Regulating Factors in Colon.
    Verstockt B; Verstockt S; Abdu Rahiman S; Ke BJ; Arnauts K; Cleynen I; Sabino J; Ferrante M; Matteoli G; Vermeire S
    J Crohns Colitis; 2021 Mar; 15(3):485-498. PubMed ID: 32915959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Farnesoid X receptor enhances epithelial ACE2 expression and inhibits virally induced IL-6 secretion: implications for intestinal symptoms of SARS-CoV-2.
    Smyth JS; Truong JK; Rao A; Lin R; Foulke-Abel J; Adorini L; Donowitz M; Dawson PA; Keely SJ
    Am J Physiol Gastrointest Liver Physiol; 2023 Nov; 325(5):G446-G452. PubMed ID: 37697930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of vitamin C and D on the mRNA expression of angiotensin converting enzyme 2 receptor, cathepsin L, and transmembrane serine protease in the mouse lungs.
    A Alruwaili M; Jarrar Y
    Libyan J Med; 2022 Dec; 17(1):2054111. PubMed ID: 35311495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada.
    Nikiforuk AM; Kuchinski KS; Twa DDW; Lukac CD; Sbihi H; Basham CA; Steidl C; Prystajecky NA; Jassem AN; Krajden M; Patrick DM; Sekirov I
    EBioMedicine; 2021 Apr; 66():103316. PubMed ID: 33819740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
    Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in the gene expression of SARS-COV-2 entry receptors and enzymes in lungs and hearts of controlled and uncontrolled diabetic mice.
    Alkhawaldeh O; Jarrar Y; Gharaibeh M; Abudahab S; Abulebdah D; Jarrar B
    Fundam Clin Pharmacol; 2024 Apr; 38(2):328-340. PubMed ID: 37950353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replication-competent vesicular stomatitis virus vaccine vector protects against SARS-CoV-2-mediated pathogenesis.
    Case JB; Rothlauf PW; Chen RE; Kafai NM; Fox JM; Shrihari S; McCune BT; Harvey IB; Smith B; Keeler SP; Bloyet LM; Winkler ES; Holtzman MJ; Fremont DH; Whelan SPJ; Diamond MS
    bioRxiv; 2020 Jul; ():. PubMed ID: 32676597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells.
    Okoloko O; Vanderwall ER; Rich LM; White MP; Reeves SR; Harrington WE; Barrow KA; Debley JS
    Front Pharmacol; 2021; 12():765951. PubMed ID: 34867390
    [No Abstract]   [Full Text] [Related]  

  • 20. Age and gender differences in ACE2 and TMPRSS2 expressions in oral epithelial cells.
    Peng J; Sun J; Zhao J; Deng X; Guo F; Chen L
    J Transl Med; 2021 Aug; 19(1):358. PubMed ID: 34412632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.